Results 101 to 110 of about 1,016 (148)

Ativação adrenérgica intramiocárdica na cardiomiopatia chagásica e doença arterial coronariana [PDF]

, 2010
Luciano Nastari, Félix José Alvarez Ramires, Vera Maria Cury Salemi, Bárbara Maria Ianni, Fábio Fernandes, Célia Maria Cássaro Strunz, Edmundo Arteaga, Charles Mady   +7 more
openalex   +1 more source

Galectin-3 Associated with Severe Forms and Long-term Mortality in Patients with Chagas Disease. [PDF]

Arq Bras Cardiol, 2021
Fernandes F, Moreira CHV, Oliveira LC, Souza-Basqueira M, Ianni BM, Lorenzo CD, Ramires FJA, Nastari L, Cunha-Neto E, Ribeiro AL, Lopes RD, Keating SM, Sabino EC, Mady C.   +13 more
europepmc   +1 more source

O papel dos miRNAs como biomarcadores na cardiomiopatia chagásica: uma revisão da literatura e análise in silico [PDF]

Introduction: Chagas cardiomyopathy (CC) is a severe form of Chagas disease (DC) and one of the main causes of cardiovascular morbidity and mortality. Dysregulation of the immune response leads to cardiac remodeling and functional changes, resulting ...
Ribeiro, Heriks Gomes
core  

Estudo do washout miocárdico de 99mTc-Sestamibi em pacientes com cardiomiopatia chagásica crônica [PDF]

, 2021
Nathália Novaes Cosenza
openalex   +1 more source

Determinants of Functional Capacity in Patients with Chagas Disease. [PDF]

Arq Bras Cardiol, 2021
Silva WT, Costa HS, Figueiredo PHS, Lima MMO, Lima VP, Costa FSMD, Ávila MR, Mendonça VA, Lacerda ACR, Nunes MCP, Rocha MOC.   +10 more
europepmc   +1 more source

SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023. [PDF]

Arq Bras Cardiol, 2023
Marin-Neto JA, Rassi A, Oliveira GMM, Correia LCL, Ramos Júnior AN, Luquetti AO, Hasslocher-Moreno AM, Sousa AS, Paola AAV, Sousa ACS, Ribeiro ALP, Correia Filho D, Souza DDSM, Cunha-Neto E, Ramires FJA, Bacal F, Nunes MDCP, Martinelli Filho M, Scanavacca MI, Saraiva RM, Oliveira Júnior WA, Lorga-Filho AM, Guimarães AJBA, Braga ALL, Oliveira AS, Sarabanda AVL, Pinto AYDN, Carmo AALD, Schmidt A, Costa ARD, Ianni BM, Markman Filho B, Rochitte CE, Macêdo CT, Mady C, Chevillard C, Virgens CMBD, Castro CN, Britto CFPC, Pisani C, Rassi DDC, Sobral Filho DC, Almeida DR, Bocchi EA, Mesquita ET, Mendes FSNS, Gondim FTP, Silva GMSD, Peixoto GL, Lima GG, Veloso HH, Moreira HT, Lopes HB, Pinto IMF, Ferreira JMBB, Nunes JPS, Barreto-Filho JAS, Saraiva JFK, Lannes-Vieira J, Oliveira JLM, Armaganijan LV, Martins LC, Sangenis LHC, Barbosa MPT, Almeida-Santos MA, Simões MV, Yasuda MAS, Moreira MDCV, Higuchi ML, Monteiro MRCC, Mediano MFF, Lima MM, Oliveira MT, Romano MMD, Araujo NNSL, Medeiros PTJ, Alves RV, Teixeira RA, Pedrosa RC, Aras Junior R, Torres RM, Povoa RMDS, Rassi SG, Alves SMM, Tavares SBDN, Palmeira SL, Silva Júnior TLD, Rodrigues TDR, Madrini Junior V, Brant VMDC, Dutra WO, Dias JCP.   +91 more
europepmc   +1 more source

Cardiomiopatia chagásica: alterações anatômicas e eletrocardiográficas

Nicole Ribeiro Cardozo, Larissa da Silveira Mattos, Ana Carolina Savioli Delorme, Alexandre Ribeiro de Menezes   +3 more
openalex   +2 more sources

Resposta cardiovascular do exercício agudo da musculatura inspiratória em pacientes com cardiomiopatia hipertensiva ou chagásica [PDF]

, 2010
Suellen Borile
openalex   +1 more source

Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Gómez-Ochoa SA, Rojas LZ, Alarcón Meléndez LJ, Quintero Santana MA, Becerra-Motta LP, Serrano-García AY, Echeverría LE.   +6 more
europepmc   +1 more source

Coronary Microvascular Dysfunction: Does it Really Matter in Chagas Disease? [PDF]

Arq Bras Cardiol, 2020
Nunes MDCP.
europepmc   +1 more source